Building efficient Alzheimer’s care

Watch Prof. Dag Åarsland, King’s College London and Stavanger University Hospital, share his thoughts on challenges that will impact radiology with the introduction of disease modifying therapies (DMTs).

With the emergence of DMTs that can slow cognitive decline, there is renewed hope for patients. At the same time, their introduction also brings new challenges for healthcare systems, particularly the increased need for MRI in both baseline assessment and ongoing monitoring during therapy.

As more patients become eligible, the demand for standardized and efficient MRI surveillance will rise. Optimized protocols, streamlined workflows, and AI-powered solutions for image reconstruction and reading can help enable faster, confident diagnosis while alleviating clinical workload in radiology.

Explore our Alzheimer’s care pathway solutions

 

Alzheimer's pathway solutions
1
WHO. Dementia – Prevalence. 
Available from: https://www.who.int/health-topics/dementia#tab=tab_2
The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results. The product/feature and/or service offerings mentioned herein are not commercially available in all countries and/or for all modalities. Their future availability cannot be guaranteed.